NCT04711551 Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics
| NCT ID | NCT04711551 |
| Status | Recruiting |
| Phase | — |
| Sponsor | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
| Condition | Musculoskeletal System Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2018-05-30 |
| Primary Completion | 2030-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2018-05-30 with a primary completion date of 2030-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study. patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments. Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.
Eligibility Criteria
Inclusion Criteria: * patients who received indication for regerative medicine treatment for one of the following pathologies: Knee or hip or ankle osteoarthritis, patellar or Achilles tendon pain, shouder or elbow pain; * males and females; * age \>= 6 years. Exclusion Criteria: * age \< 6 years * patients not compliant with post-treatment monitoring procedures * pregnancy
Contact & Investigator
Laura De Girolamo
PRINCIPAL INVESTIGATOR
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Frequently Asked Questions
Who can join the NCT04711551 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Musculoskeletal System Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04711551 currently recruiting?
Yes, NCT04711551 is actively recruiting participants. Contact the research team at laura.degirolamo@grupposandonato.it for enrollment information.
Where is the NCT04711551 trial being conducted?
This trial is being conducted at Milan, Italy, Milan, Italy.
Who is sponsoring the NCT04711551 clinical trial?
NCT04711551 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. The principal investigator is Laura De Girolamo at I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. The trial plans to enroll 2,000 participants.